Focused ultrasound-mediated temozolomide delivery into intact blood-brain barrier tissue improves survival in patient-derived xenograft model of glioblastoma.

Fluids Barriers CNS · 2025 · PMC12376472 · PMID 40855299

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, applying FUS in the early treatment phase (1-day group) showed a trend toward better tumor suppression and survival outcomes compared to that at later time points.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.